RenovoRx, Inc. (RNXT) stock
RNXTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.12+0.08 (+7.69%)
Close on Nov 18, 2026Market cap $50.55MP/E –Yield –
RenovoRx shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
RenovoRx's shares outstanding was 47M at Jun 30, 2026. For fiscal 2025 it was 35M, up 58.6% from the year before. The highest annual figure on record is 35M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 35M | +58.6% |
| FY2024 | Dec 31, 2024 | 22M | +116.4% |
| FY2023 | Dec 31, 2023 | 10M | +13.7% |
| FY2022 | Dec 31, 2022 | 9M | +73.5% |
| FY2021 | Dec 31, 2021 | 5M | +135.6% |
| FY2020 | Dec 31, 2020 | 2M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 47M | +29.3% |
| Q1 FY2026 | Mar 31, 2026 | 38M | +21.1% |
| Q4 FY2025 | Dec 31, 2025 | 37M | +46.0% |
| Q3 FY2025 | Sep 30, 2025 | 37M | +46.9% |
| Q2 FY2025 | Jun 30, 2025 | 37M | +52.1% |
| Q1 FY2025 | Mar 31, 2025 | 31M | +110.0% |
| Q4 FY2024 | Dec 31, 2024 | 25M | +134.7% |
| Q3 FY2024 | Sep 30, 2024 | 25M | +133.2% |
| Q2 FY2024 | Jun 30, 2024 | 24M | +125.7% |
| Q1 FY2024 | Mar 31, 2024 | 15M | +64.4% |
| Q4 FY2023 | Dec 31, 2023 | 11M | +17.7% |
| Q3 FY2023 | Sep 30, 2023 | 11M | +17.9% |
| Q2 FY2023 | Jun 30, 2023 | 11M | +17.6% |
| Q1 FY2023 | Mar 31, 2023 | 9M | +1.1% |
| Q4 FY2022 | Dec 31, 2022 | 9M | -8.6% |
| Q3 FY2022 | Sep 30, 2022 | 9M | +61.3% |
| Q2 FY2022 | Jun 30, 2022 | 9M | +296.4% |
| Q1 FY2022 | Mar 31, 2022 | 9M | +301.1% |
| Q4 FY2021 | Dec 31, 2021 | 10M | +361.5% |
| Q3 FY2021 | Sep 30, 2021 | 6M | +148.3% |
| Q2 FY2021 | Jun 30, 2021 | 2M | – |
| Q1 FY2021 | Mar 31, 2021 | 2M | – |
| Q4 FY2020 | Dec 31, 2020 | 2M | – |
| Q3 FY2020 | Sep 30, 2020 | 2M | – |
See a number that looks wrong?